Types of Stem Cells Explained: Totipotent, Pluripotent, Multipotent & Unipotent

A stem cell is an unspecialized cell with two defining properties: self-renewal (it can divide to produce more stem cells) and differentiation (it can mature into specialized cell types such as neurons, cartilage, or blood cells). Every tissue in the human body originated from stem cells.

Not all stem cells are equal. The range of cell types a stem cell can produce is called its potency, and potency defines the four major classes used in biology and medicine.

Totipotent cells are the most powerful — they can develop into any cell type in the body, plus extra-embryonic tissues such as the placenta. In humans, totipotent cells exist only in the very early embryo, from the moment of fertilization through the first few cell divisions (roughly the first 4 days).

Totipotent cells are not used in clinical regenerative medicine. Their isolation is biologically and ethically impossible outside the very earliest stage of embryonic development, and their unrestricted differentiation potential makes them inherently unsuitable for therapeutic delivery.

Pluripotent stem cells can differentiate into any cell of the three primary germ layers — endoderm, mesoderm, and ectoderm — which together form every tissue of the body, but not extra-embryonic tissue. Two main pluripotent cell types exist: embryonic stem cells (ESCs), derived from the inner cell mass of a 5–7 day blastocyst, and induced pluripotent stem cells (iPSCs), reprogrammed in the laboratory from adult cells.

Pluripotent cells are the focus of intense research because of their broad differentiation capacity, but they carry a meaningful clinical limitation: their unrestricted growth potential makes them prone to forming teratomas (benign tumors containing multiple tissue types) if delivered before being properly differentiated. For this reason, pluripotent cells are not directly infused into patients — they are first differentiated in the lab into a specific, mature cell type before any clinical use.

Multipotent stem cells can differentiate into a limited family of related cell types. The two most clinically important multipotent cells are hematopoietic stem cells (HSCs), which produce all blood and immune cell lineages and are the basis of bone marrow transplantation, and mesenchymal stem cells (MSCs), which can differentiate into bone, cartilage, fat, tendon, and stromal cells.

MSCs are the dominant cell type in modern regenerative medicine, and their primary therapeutic mechanism is not direct differentiation — it is paracrine signaling. MSCs release a complex secretome of cytokines, growth factors, and extracellular vesicles (exosomes) that modulate inflammation, support tissue repair, and regulate the immune system. This is why MSCs are used to treat conditions as diverse as osteoarthritis, autoimmune disease, neurological injury, and inflammatory disorders.

At TurkeyStemcell, all clinical protocols use Wharton's jelly MSCs — neonatal mesenchymal stem cells sourced from ethically donated umbilical cord tissue and produced in a GMP-certified laboratory. Wharton's jelly MSCs are preferred over adult bone marrow or adipose MSCs because they are younger, more proliferative, and immunologically privileged for allogeneic use.

Unipotent stem cells can produce only one specific cell type. The most familiar example is the spermatogonial stem cell, which differentiates exclusively into sperm. Epidermal basal cells, which regenerate skin throughout life, are also unipotent.

Unipotent cells have important roles in tissue maintenance and in research, but they are rarely used in cell-therapy products because their narrow lineage limits clinical applications compared with the broader signaling effects of multipotent MSCs.

Totipotent: any body cell + placenta. Source: very early embryo. Clinical use: none.

Pluripotent: any body cell (no placenta). Source: blastocyst (ESC) or reprogrammed adult cells (iPSC). Clinical use: research and pre-differentiated derivatives only.

Multipotent: a family of related cells (e.g. bone, cartilage, fat for MSCs). Source: umbilical cord, bone marrow, adipose tissue. Clinical use: widespread — the basis of most regenerative medicine programs.

Unipotent: one specific cell type. Source: adult tissue. Clinical use: limited, mostly tissue-specific repair research.

Modern regenerative medicine — including the protocols offered at TurkeyStemcell for orthopedic, autoimmune, neurological, and anti-aging indications — uses multipotent mesenchymal stem cells, almost always from umbilical cord Wharton's jelly.

Wharton's jelly MSCs combine the advantages of neonatal cell biology (longer telomeres, stronger proliferative capacity, lower senescence) with ethical sourcing (collected after healthy full-term births from tissue that would otherwise be discarded) and allogeneic compatibility (low HLA-II expression, no HLA matching required).

Exosome therapy — increasingly used alongside MSC therapy — is a cell-free extension of this approach. Exosomes are extracellular vesicles released by MSCs that carry the same regenerative signaling cargo without the need to deliver living cells. See our exosome vs stem cell therapy comparison for a full breakdown.